Laboratorio Farmaceutico Erfo Logo

Laboratorio Farmaceutico Erfo

Full-service contract manufacturer of private label supplements and medical devices.

ERFO | XMIL

Overview

Corporate Details

ISIN(s):
IT0005497836 (+1 more)
LEI:
8945005CB564D0OBQQ85
Country:
Italy
Address:
VIALE GEKI RUSSO, SNC (PONTE GALLO), 98049 VILLAFRANCA TIRRENA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Farmaceutico Erfo S.p.A. is an innovative company specializing in the nutraceutical sector. The firm provides contract manufacturing services for food supplements and medical devices, offering a comprehensive, end-to-end solution for third-party brands. Its services span the entire product development lifecycle, from formulation and raw material selection to production, packaging design, and legal consulting. Operating from a modern, ISO 9001:2015 certified facility authorized by the Italian Ministry of Health, Erfo supports clients with both small-batch and large-scale production runs for private label products. The company manufactures various pharmaceutical forms, including capsules, tablets, sachets, vials, and bottles. Erfo is a registered Benefit Corporation (Società Benefit).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 07:27
Regulatory Filings
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IIIQ 2025
Italian 696.9 KB
2025-11-11 08:24
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione regolamento attuativo piano…
Italian 410.6 KB
2025-10-17 08:00
Regulatory Filings
ERFO parteciperà alla sesta edizione della conferenza "NEXT GEMS"
Italian 453.6 KB
2025-10-15 19:00
Remuneration Information
Laboratorio Farmaceutico Erfo S.p.A. - Assemblea approva piano di incentivazion…
Italian 403.6 KB
2025-09-30 17:09
Pre-Annual General Meeting Information
Laboratorio Farmaceutico Erfo S.p.A. - Pubblicazione Avviso di Convocazione e d…
Italian 450.0 KB
2025-09-27 16:21
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Approvazione relazione semestrale consol…
Italian 1.5 MB
2025-08-28 18:09
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A.: 1H 2025 financial figures
English 502.5 KB
2025-08-28 13:00
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IH 2025
Italian 334.1 KB
2025-08-20 23:05
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-08-09 11:14
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.2 KB
2025-08-02 09:19
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.9 KB
2025-07-25 20:05
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 374.5 KB
2025-07-18 20:04
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.1 KB
2025-07-12 09:39
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-07-04 18:21
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.3 KB

Automate Your Workflow. Get a real-time feed of all Laboratorio Farmaceutico Erfo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorio Farmaceutico Erfo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorio Farmaceutico Erfo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MACROGENICS INC Logo
Biopharma firm developing innovative antibody-based therapeutics for cancer treatment.
United States of America
MGNX
MADRIGAL PHARMACEUTICALS, INC. Logo
Develops and delivers the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO for pharma/med device firms, offering end-to-end development and specialized manufacturing.
Sweden
MAGLE
MAIA Biotechnology, Inc. Logo
Developing telomere-targeting immuno-oncology therapies for difficult-to-treat cancers.
United States of America
MAIA
Develops at-home diagnostic tests for the early detection of life-threatening cancers.
Germany
MYNZ
MANNKIND CORP Logo
Develops inhaled therapies for endocrine, orphan lung, and cardiometabolic diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Provides nucleic acid products and biologics safety testing for new therapies and vaccines.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops virus-blocking products & immunology therapies via proprietary technology platforms.
Austria
MARI
Marker Therapeutics, Inc. Logo
Developing non-genetically modified T cell immunotherapies for hematologic and solid tumors.
United States of America
MRKR
Maze Therapeutics, Inc. Logo
Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.
United States of America
MAZE

Talk to a Data Expert

Have a question? We'll get back to you promptly.